Possible Role of Toll-like Receptor-2 in the Intracellular Survival of Staphylococcus aureus in Murine Peritoneal Macrophages: Involvement of Cytokines and Anti-Oxidant Enzymes

Scandinavian Journal of Immunology

Volumn 80, Issue 2, 2014, Pages 127-143

  Bishayi, B ^a   Bandyopadhyay, D ^a   Majhi, A ^a   Adhikary, R ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMITROLE; ANTIOXIDANT; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TRIAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BACTERIAL LOAD; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; WESTERN BLOTTING;

AMITROLE; ANIMALS; ANTIBODIES; CATALASE; CYTOKINES; HYDROGEN PEROXIDE; MACROPHAGES, PERITONEAL; MALE; MICE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; NITRIC OXIDE; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPEROXIDE DISMUTASE; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTOR RELA;

EID: 84903899737     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12195     Document Type: Article

References (69)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
2. Kubica M, Guzik K, Koziel J et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008;3:e1409.
3. Fournier B. The function of TLR2 during Staphylococcal diseases. Front Cell Infect Microbiol 2013;2:167.
4. Silva MT. Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation. J Leukoc Biol 2011;89:675-83.
5. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20.
6. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000;165:5392-6.
7. Knuefermann P, Sakata Y, Baker JS et al. Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 2004;110:3693-8.
8. Spiller S, Elson G, Kirschning CJ et al. TLR-4 induced IFN-γ production increases TLR-2 sensitivity and drives Gram negative sepsis in mice. J Exp Med 2008;205:1747-54.
9. Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T-cells. J Immunol 2004;172:3712-8.
10. Arko-Mensah J, Julian E, Singh M et al. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-γ induced killing of Mycobacteria by murine macrophages. Scand J Immunol 2007;65:148-57.
11. Netea MG, Van der Meer JWM, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 2004;12:484-8.
12. Watanabe I, Ichiki M, Shiratsuchi A et al. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol 2007;178:4917-25.
13. Singh A, Rost D, Tvardovskaia N et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10 mediated immunosuppression. J Exp Med 2002;196:1017-24.
14. Strunk T, Power Coombs MR, Currie AJ et al. TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS One 2010;5:e10111.
15. Dong C, Sexton H, Gertrudes A et al. Inhibition of toll-like receptor-mediated inflammation in vitro and in vivo by a novel benzoxaborole. J Pharmacol Exp Ther 2013;344:436-46.
16. Kondo T, Kawai T, Akira S. Dissecting negative regulation of toll-like receptor signalling. Trends Immunol 2012;33:450-60.
17. Yang HZ, Cui B, Liu HZ et al. Blocking TLR-2 activity attenuates pulmonary metastasis of tumor. PLoS One 2009;4:e6520.
18. Weiss DJ, Souza CD, Evanson OA et al. Bovine monocyte TLR2 receptors differentially regulate the intracellular fate of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium. J Leukoc Biol 2008;83:48-55.
19. Ultaigh SNA, Saber TP, McCormick J et al. Blockade of TLR2 prevents spontaneous and induced cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Rheum 2010;62 (Suppl. 10):16.
20. Kim S, Takahashi H, Lin WW et al. Carcinoma produced factors activates myeloid cells via TLR2 to stimulate metastasis. Nature 2009;457:102-6.
21. Yan J, Hua F, Liu H et al. Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice. Acta Pharmacol Sin 2012;33:503-12.
22. Ajuwon KM, Banz W, Winters TA. Stimulation with peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant down regulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes. J Inflamm 2009;6:8.
23. Meng G, Rutz M, Schiemann M et al. Antagonistic antibody prevents toll-like receptor 2- driven lethal shock like syndromes. J Clin Invest 2004;113:1473-81.
24. Liu T, Matsuguchi T, Tsuboi N et al. Differences in expression of Toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 2002;70:6638-45.
25. 2 produced by the murine peritoneal macrophages. Microb Pathog 2009;47:57-67.
26. Paul-Clark MJ, McMaster SK, Sorrentino R et al. Toll-like receptor 2 is essential for sensing of oxidants during inflammation. Am J Respir Crit Care Med 2009;179:299-306.
27. Sorci G, Faivre B. Inflammation and oxidative stress in vertebrate host-parasite system. Philos Trans R Soc Lond B Biol Sci 2009;364:71-83.
28. West AP, Brodsky IE, Rahner C et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476-82.
29. Martínez-Pulgarín S, Dominguez-Bernal G, Orden JA et al. Simultaneous lack of catalase and beta-toxin in Staphylococcus aureus leads to increased intracellular survival in macrophages and epithelial cells and to attenuated virulence in murine and ovine models. Microbiology 2009;155:1505-15.
30. Mal P, Dutta S, Bandyopadhyay D et al. Gentamicin in combination with ascorbic acid regulates the severity of Staphylococcus aureus infection-induced septic arthritis in mice. Scand J Immunol 2012;76:528-40.
31. Das D, Bishayi B. Contribution of catalase and superoxide dismutase to the intracellular survival of clinical isolates of Staphylococcus aureus in murine macrophages. Indian J Microbiol 2010;50:375-84.
32. + T cell activation via Toll-like receptors 1 and 2. Infect Immun 2011;79:663-73.
33. Swisher JFA, Burton N, Bacot SM et al. Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 2010;115:549-58.
34. Gebbia JA, Coleman JL, Benach JL. Selective induction of matrix metalloproteinases by Borrelia burgdorferi via Toll-like receptors 2 in monocytes. J Infect Dis 2004;189:113-9.
35. Sen R, Das D, Bishayi B. Staphylococcal catalase regulates its virulence and induces arthritis in catalase deficient mice. Indian J Physiol Pharmacol 2009;53:307-17.
36. Cosgrove KG, Coutts IM, Jonsson A et al. Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol 2007;189:1025-35.
37. Able AJ, Guest DI, Sutherland MW. Hydrogen peroxide yields during the incompatible interaction of tobacco suspension cells inoculated with Phytophthora nicotianae. Plant Physiol 2000;124:899-910.
38. Mal P, Ghosh D, Bandyopadhyay D et al. Ampicillin alone and in combination with riboflavin modulates Staphylococcus aureus infection induced septic arthritis in mice. Indian J Exp Biol 2012;50:677-89.
39. Mal P, Dutta K, Bandyopadhyay D et al. Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res 2013;62:259-73.
40. Leigh PCJ, van Furth R, van Zwet TL. In vitro determination of phagocytosis and intracellular killing by polymorphonuclear and mononuclear phagocytes. In: Weir DM, ed. Handbook of Experimental Immunology. Oxford: Blackwell Scientific Publications, 1986:4:46.1-46.26.
41. Nandi D, Mishra MK, Basu A et al. Protective effects of interleukin-6 in lipopolysaccharide (LPS)-induced experimental endotoxemia is linked to alteration in hepatic anti-oxidant enzymes and endogenous cytokines. Immunobiology 2010;215:443-51.
42. Blair P, Rex S, Vitseva O et al. Stimulation of Toll-like receptor 2 in human platelets induces a thrombo inflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009;104:346-54.
43. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR 2 and TLR 4 in recognition of Gram negative and Gram positive bacterial cell wall components. Immunity 1999;11:443-51.
44. Rogers DE, Tompsett R. The survival of staphylococci within human leukocytes. J Exp Med 1952;95:209-30.
45. Voyich JM, Braughton KR, Sturdevant DE et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005;175:3907-19.
46. Uzzau S, Bossi L, Figueroa-Bossi N. Differential accumulation of Salmonella (Cu, Zn) superoxide dismutases Sod CI and Sod CII in intracellular bacteria: correlation with their relative contribution to pathogenicity. Mol Microbiol 2002;46:147-56.
47. Stortz G, Tartaglia LA, Ames BN. Transcriptional regulation of oxidative stress inducible genes: direct activation by oxidation. Science 1990;248:189-94.
48. Basu M, Czinn SJ, Blanchard TG. Absence of catalase reduces long term survival of Helicobacter pylori in macrophage phagosomes. Helicobacter 2004;9:211-6.
49. Day WA, Sajecki JL, Pitts TM et al. Role of catalase in Campylobacter jejuni intracellular survival. Infect Immun 2000;68:6337-45.
50. Manca C, Paul S, Barry CE et al. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 1999;67:74-9.
51. Wood RI, Legg PG. Peroxidase activity in rat liver microbodies after aminotriazole inhibition. J Cell Biol 1970;45:576-85.
52. Takehisha M, Horiuchi K, Hidaka E et al. Isolation and molecular categorization of Catalase-negative Staphylococcus aureus from sputum of a patient with aspiration pneumonia. Jpn J Infect Dis 2012;65:439-41.
53. Roos D, Weening RS, Wyss SR et al. Protection of human neutrophils by endogenous Catalase. J Clin Invest 1980;65:1515-22.
54. Ghadermarzi M, Moosavi-Movahedi AA. Determination of the kinetic parameters for the "suicide substrate" inactivation of bovine liver catalase by hydrogen peroxide. J Enzyme Inhib 1996;10:167-75.
55. García-Molina F, Hiner ANP, Fenoll LG et al. Mushroom tyrosinase: catalase activity, inhibition, and suicide inactivation. J Agric Food Chem 2005;53:3702-9.
56. Finlay B, Falkow S. Common themes in microbial pathogeneicity revisited. Microbiol Mol Biol Rev 1997;61:136-69.
57. Lu Y, Wang Y, Ling B et al. Catalase-negative Staphylococcus lugdunensis strain with a Novel point mutation in the catalase gene isolated from a patient with chronic suppurative otitis media. J Clin Microbiol 2013;51:1310.
58. Geiger T, Francois P, Liebeke M et al. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMS expression. PLoS Pathog 2012;8:e1003016.
59. Thwaites GE, Gant V. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol 2011;9:215-22.
60. Gresham HD, Lowrance JH, Caver TE et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000;164:3713-22.
61. van Dissel JT, van Langevelde P, Westendorp RG et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950-3.
62. Deering RP, Orange JS. Development of a clinical assay to evaluate toll-like-receptor function. Clin Vaccine Immunol 2006;13:68-76.
63. Bohacek I, Cordeau P, Lalancette-Hébert M et al. Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J Neuroinflammation 2012;9:191.
64. Wang J, Roderiquez G, Norcross MA. Control of adaptive immune responses by Staphylococcus aureus through IL-10, PD-L1, and TLR-2. Sci Rep 2012;2:606.
65. Netea MG, Van der Meer JW, Sutmuller RP et al. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother 2005;49:3991-6.
66. Lew BL, Sim WY, Kim NI. Expression of Toll-like receptor 2 in cultured human keratinocytes: the effect of bacterial antigens, cytokines and calcium concentration. Ann Dermatol 2009;21:337-44.
67. Steege JC, van de Ven WC, Forget PP et al. Regulation of lipopolysaccharide induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-gamma, tumor necrosis factor-alpha, and interleukin-10. Eur Cytokine Netw 1998;10:115-23.
68. Giese NA, Gabriele L, Doherty TM et al. Interferon (IFN) consensus sequence binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med 1997;186:1535-46.
69. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.